Status:
COMPLETED
Validation of an Electronic Remote Toxicity Management System in Cancer Patients
Lead Sponsor:
Centre Hospitalier Régional Metz-Thionville
Conditions:
Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
To assess the psychometric properties (validity, reliability and responsiveness) of the QuestOnco tool, an electronic Remote Toxicity Management System, in adult cancer patients receiving an active an...
Detailed Description
In this study, a mobile phone-based remote monitoring system (QuestOnco application) was developed in order to enable the 'real-time' monitoring of patients' symptoms through use of ePROMs. In order t...
Eligibility Criteria
Inclusion
- Adults (≥18 years);
- Written and informed consent;
- Diagnosis of solid cancer;
- Metastatic or (neo)adjuvant anti-cancer treatment, including intravenous and/or oral treatments;
- Patient physically/psychologically fit to participate in the study;
- Patient able to understand, communicate and use the electronic device;
- Patient owning a smartphone or tablet with internet connection;
- Treatment supported by the French social security system.
Exclusion
- Unable patient for signing informed consent;
- Unable to understand, communicate and use the electronic device;
- Patient under trusteeship or guardianship;
- Patient under legal or administration protection.
Key Trial Info
Start Date :
May 18 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 12 2022
Estimated Enrollment :
134 Patients enrolled
Trial Details
Trial ID
NCT04915274
Start Date
May 18 2021
End Date
January 12 2022
Last Update
January 18 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Régional Metz-Thionville
Metz, France, 57085